FYI from the NHLBI Index
September 2012: Vol. 13, Issue 2
Research and Resources
NHLBI Research Initiatives
- Ancillary Studies in Clinical Trials (R01)
- Cardiovascular Risk Reduction in Underserved Rural Communities (R01)
- NHLBI Systems Biology Collaborations (R01)
- Mentored Career Award for Faculty at Institutions That Promote Diversity (K01)
- Integrative Omics Data Analysis for Discovery in Lung Diseases (R01)
- Mentored Career Development Award to Promote Faculty Diversity/Re-Entry in Biomedical Research (K01)
- Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25)
- Comparison of Strategies to Study Pediatric Pulmonary Vascular Disease Outcomes Using Bioinformatics (U01)
- NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44)
Need More Information?
NHLBI Research Initiatives
From time to time, the NHLBI invites investigators to submit grant applications
or contract proposals for specific research programs. We are soliciting
applications for the new programs described below. Please visit the URL listed with each program to obtain information
about application dates and deadlines. For full details of these and other current research initiatives,
Ancillary Studies in Clinical Trials (R01)
- Initiative Number: RFA-HL-13-003
- Objective: Conduct time-sensitive ancillary studies related to heart, lung, and blood diseases and sleep disorders in conjunction with
ongoing clinical trials and other large clinical studies.
Cardiovascular Risk Reduction in Underserved Rural Communities (R01)
- Initiative Number: RFA-HL-13-013
- Objective: Develop well-designed, controlled trials of approaches to reduce cardiovascular disease risk factors in rural communities.
NHLBI Systems Biology Collaborations (R01)
- Initiative Number: PAR-12-138
- Objective: Develop collaborative, multi-disciplinary systems biology research projects to advance our understanding of normal
physiology and perturbations associated with heart, lung, blood, and sleep diseases and disorders.
Mentored Career Award for Faculty at Institutions That Promote Diversity (K01)
- Initiative Number: RFA-HL-13-018
- Objective: Provide support for faculty at institutions that train substantial numbers of students from disadvantaged
backgrounds, receive modest research support from the NHLBI, and provide health-related services and education to minority
and other health disparity populations.
Integrative Omics Data Analysis for Discovery in Lung Diseases (R01)
- Initiative Number: PAR-12-155
- Objective: Generate systems-level models of pulmonary pathobiology through analyses of existing omics data and test the
models using human tissues/cells and/or mammalian animal models.
Mentored Career Development Award to Promote Faculty Diversity/Re-Entry in Biomedical Research (K01)
- Initiative Number: RFA-HL-13-019
- Objective: Increase the number of highly trained investigators who come from backgrounds underrepresented in research
areas of interest to the NHLBI or who wish to re-enter their research careers after a hiatus due to family responsibilities.
Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25)
- Initiative Number: RFA-HL-13-020
- Objective: : Promote diversity in undergraduate and health professional participant populations by providing
short-term research education support to stimulate career development in cardiovascular, pulmonary, hematologic, and
sleep disorders research.
Comparison of Strategies to Study Pediatric Pulmonary Vascular Disease Outcomes Using Bioinformatics (U01)
- Initiative Number: RFA-HL-14-005
- Objective: Compare the ability of two data sources, electronic health records and traditional prospective patient-based
clinical and research data, to answer research questions regarding the natural history, longitudinal outcomes, and phenotypes
of therapeutic response for pediatric pulmonary vascular disease.
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44)
- Initiative Number: RFA-HL-13-016
- Objective: Facilitate and accelerate the capital-intensive steps that are required to transition SBIR Phase II projects to the
commercialization stage by promoting partnerships between SBIR Phase II awardees and third-party investors and/or strategic partners.
[Back to Top]
[Table of Contents]
Need More Information?
We are always interested in receiving comments and suggestions from the community.
If you or your organizations have questions for me or for the Institute, please
contact me at email@example.com or Dr. Carl
Roth at firstname.lastname@example.org.
Gary H. Gibbons, M.D.
For information on specific issues, the following contacts may be helpful:
For health related questions and publications, please contact the trained information specialists at the NHLBI Information Center (NHLBIinfo@nhlbi.nih.gov) or write to the Information Center at P.O. Box 30105, Bethesda, MD 20824-0105.
For communications pertaining to NHLBI policies and priorities, contact the NHLBI Office of Public Liaison, (email@example.com).
For additional information regarding NHLBI events, consult the references provided or NHLBI Calendar. Most other NIH Institutes and Centers also maintain calendars on their websites. Links to their Web pages are at NIH Institutes, Centers, and Offices.
For Web related matters pertaining to the online version of the FYI from the NHLBI, contact the FYI from the NHLBI's Web Editor.
Please send us your feedback, comments, and questions by using the appropriate link on the page,
Contact the NHLBI.
Note to users of screen readers and other assistive technologies: please report
your problems here.
Last Updated May 2012